Pharmacokinetic and pharmacodynamic actions of clozapine-N-oxide, clozapine, and compound 21 in DREADD-based chemogenetics in mice

Muscarinic Designer Receptors Exclusively Activated by Designer Drugs (DREADD) gated by clozapine-N-oxide (CNO) allow selective G-protein cascade activation in genetically specified cell-types in vivo . Here we compare the pharmacokinetics, off-target effects and efficacy of CNO, clozapine (CLZ) and...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Scientific reports Ročník 9; číslo 1; s. 4522
Hlavní autoři:	Jendryka, Martin, Palchaudhuri, Monika, Ursu, Daniel, van der Veen, Bastiaan, Liss, Birgit, Kätzel, Dennis, Nissen, Wiebke, Pekcec, Anton
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	London Nature Publishing Group UK 14.03.2019 Nature Publishing Group
Témata:	14/19 631/378/2649/2150 64/60 692/4017 82/80 96/106 Acetylcholine receptors (muscarinic) Animals Bioavailability Cell activation Cells, Cultured Cerebrospinal fluid Clozapine Clozapine - analogs & derivatives Clozapine - analysis Clozapine - metabolism Clozapine - pharmacokinetics Drug dosages Half-Life Humanities and Social Sciences Ligands Male Metabolites Mice Mice, Inbred C57BL multidisciplinary Neurons - cytology Neurons - metabolism Pharmacodynamics Pharmacokinetics Piperazines - analysis Piperazines - metabolism Piperazines - pharmacokinetics Plasma Proteins Rats Rats, Sprague-Dawley Science Science (multidisciplinary)
ISSN:	2045-2322, 2045-2322
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Buďte první, kdo okomentuje tento záznam!